Is the use of antifungal management advisable in critical patients with positive isolation of Candida spp. from intraabdominal clinical samples?;¿Implica el aislamiento de Candida spp. en muestras intraabdominales de pacientes críticos la necesidad de tratamiento antifúngico?

Revista Iberoamericana de Micologia

Volumn 25, Issue 4, 2008, Pages 203-207

  Zaragoza, Rafael ^a   Pemán, Javier ^b   Salavert, Miguel ^b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Acute pancreatitis; Antifungal treatment; CAGTA; Candida peritonitis; Candida score; PCR; Surgical patients; Yeast colonization

Indexed keywords

ANTIFUNGAL AGENT; FUNGAL DNA; FUNGUS ANTIBODY;

ABDOMINAL INFECTION; ABDOMINAL SURGERY; ARTICLE; CANDIDA ALBICANS; CLINICAL EVALUATION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FUNGAL COLONIZATION; FUNGAL DETECTION; FUNGUS ISOLATION; HUMAN; INFECTION PREVENTION; INTENSIVE CARE; INVASIVE CANDIDIASIS; NONHUMAN; PANCREATITIS; PERIOPERATIVE PERIOD; PERITONEAL FLUID; PERITONITIS; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; SURGICAL DRAINAGE; ACUTE HEMORRHAGIC PANCREATITIS; ADULT; CANDIDIASIS; CHOLECYSTITIS; FUNGEMIA; IMMUNOLOGY; METHODOLOGY; MICROBIOLOGY; POSTOPERATIVE COMPLICATION;

CANDIDA; CANDIDA ALBICANS;

ADULT; ANTIBODIES, FUNGAL; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; CHOLECYSTITIS; CRITICAL CARE; DNA, FUNGAL; FUNGEMIA; HUMANS; PANCREATITIS, ACUTE NECROTIZING; PERITONITIS; POSTOPERATIVE COMPLICATIONS;

EID: 61449492479     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(08)70049-4     Document Type: Article

References (23)

1. De Waele JJ, Vogelaers D, Blot S, Colardyn F. Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis 2003; 37: 208-213.
2. Diebel LN, Raafat AM, Dulchavsky SA, Brown WJ. Gallbladder and biliary tract candidiasis. Surgery 1996; 120: 760-764.
3. Dupont H, Bourichon A, Paugam-Burtz C, Mantz J, Desmonts JM. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis? Crit Care Med 2003; 31: 752-757.
4. Dupont H, Paugam-Burtz C, Muller-Serieys C, Fierobe L, Chosidow D, Marmuse JP, Mantz J, Desmonts JM. Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 2002; 137: 1341-6.
5. Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, Chiolero R, Pannatier A, Schilling J, Geroulanos S, Glauser MP, Calandra T. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27: 1066-1072.
6. Eggimann P, Jamdar S, Siriwardena AK. Pro/con debate: antifungal prophylaxis is important to prevent fungal infection in patients with acute necrotizing pancreatitis receiving broad-spectrum antibiotics. Crit Care 2006; 10: 229.
7. Gloor B, Muller CA, Worni M, Stahel PF, Redaelli C, Uhl W, Buchler MW. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg 2001; 136: 592-596.
8. Gotzinger P, Wamser P, Barlan M, Sautner T, Jakesz R, Fugger R. Candida infection of local necrosis in severe acute pancreatitis is associated with increased mortality. Shock 2000; 14: 320-323.
9. He YM, Lv XS, Ai ZL, Liu ZS, Qian Q, Sun Q, Chen JW, Lei DX, Jiang CQ, Yuan YF. Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study. World J Gastroenterol 2003; 9: 2619-2621.
10. Hoerauf A, Hammer S, Muller-Myhsok B, Rupprecht H. Intra-abdominal Candida infection during acute necrotizing pancreatitis has a high prevalence and is associated with increased mortality. Crit Care Med 1998; 26: 2010-2015.
11. Leon C, Alvarez-Lerma F, Ruiz-Santana S, Leon MA, Nolla-Salas J, Jorda R, Saavedra P, Palomar M, The EPCAN study group. Fungal colonization and/ or infection in nonneutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis 2008; in press.
12. Leon C, Ruiz-Santana S, Saavedra P, Almirante B, Nolla-Salas J, Alvarez-Lerma F, Garnacho-Montero J, Leon MA. A bedside scoring system ("Candida score") for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34: 730-737.
13. McMullan R, Metwally L, Coyle PV, Hedderwick S, McCloskey B, O'Neill HJ, Patterson CC, Thompson G, Webb CH, Hay RJ. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008; 46: 890-896.
14. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, Hennequin C, Martin C. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006; 34: 646-652.
15. Nolla-Salas J, Sitges-Serra A, Leon-Gil C, Martinez-Gonzalez J, Leon-Regidor MA, Ibanez-Lucia P, Torres-Rodriguez JM. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med 1997; 23: 23-30.
16. Petri MG, Konig J, Moecke HP, Gramm HJ, Barkow H, Kujath P, Dennhart R, Schafer H, Meyer N, Kalmar P, Thulig P, Muller J, Lode H. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 1997; 23: 317-325.
17. Rodriguez VE, Freuler CB, Ezcurra C, Durlach RA. Colecistitis aguda e infección de la vía biliar por Candida. Rev Iberoam Micol 2007; 24: 152-154.
18. Sandven P, Qvist H, Skovlund E, Giercksky KE. Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. Crit Care Med 2002; 30: 541-547.
19. Vincent JL, Anaissie E, Bruining H, Demajo W, el Ebiary M, Haber J, Hiramatsu Y, Nitenberg G, Nystrom PO, Pittet D, Rogers T, Sandven P, Sganga G, Schaller MD, Solomkin J. Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998; 24: 206-216.
20. Zaragoza R, Pemán J. The diagnostic and therapeutic approach to fungal infections in critical care settings. Adv Sepsis 2008; 6: 90-98.
21. Zaragoza R, Pemán J. Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy. Rev Iberoam Micol 2006; 23: 59-63.
22. Zaragoza R, Pemán J, Quindós G, Iruretagoyena JR, Cuetara M, Ramirez P, Gomez D, Camarena J, Viudes A, Ponton J, on behalf of the study group Candida albicans Germ Tube Antibody Detection in Critically Ill Patients (CAGTAUCI). Clinical significance of Candida albicans germ tube antibody detection in critically ill patients. Clin Microbiol Infect 2008; in press.
23. Zaragoza R, Pemán J, Salavert M, Viudes A, Sole A, Jarque I, Monte E, Roma E, Canton E. Multidisciplinary approach to the treatment of invasive fungal infections. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts? Ther Clin Risk Management 2008; in press.